BACKGROUND: The Organ Procurement and Transplantation Network (OPTN) requires specific informed consent when "increased risk" (IR) donor organs are utilized. Little is known about kidney transplant candidates' understanding of IR donor kidneys. METHODS: We assessed kidney transplant candidates' perceptions, reasons for accepting or declining a future IR donor kidney offer, and information needs through semi-structured interviews. RESULTS: One hundred and sixty-two (80%) patients participated. Patients perceived IR donors as having poor health (44%), advanced age (38%), and poor kidney quality (24%). Patients (31%) would accept IR donor kidneys to get off dialysis (n=18/50), to improve health by receiving a transplant quickly (n=13/50), and felt that the risk of infection was low (n=10/50). Patients (47%) would decline IR donor kidneys for fear of infection transmission (n=34/76), perceived poor-quality kidneys (n=32/76), and their health was good enough to wait for an average-risk kidney (n=23/76). Undecided patients (22%) needed information about the donation situation. Patients desired information about IR donors, their kidneys, and their impact on patients' health. CONCLUSIONS: Patients confuse risk posed by OPTN-defined IR donors and other non-standard risk donors. Greater efforts are needed to educate kidney transplant candidates about IR donor kidneys and refine terminology used to describe risks to patients.
BACKGROUND: The Organ Procurement and Transplantation Network (OPTN) requires specific informed consent when "increased risk" (IR) donor organs are utilized. Little is known about kidney transplant candidates' understanding of IR donor kidneys. METHODS: We assessed kidney transplant candidates' perceptions, reasons for accepting or declining a future IR donor kidney offer, and information needs through semi-structured interviews. RESULTS: One hundred and sixty-two (80%) patients participated. Patients perceived IR donors as having poor health (44%), advanced age (38%), and poor kidney quality (24%). Patients (31%) would accept IR donor kidneys to get off dialysis (n=18/50), to improve health by receiving a transplant quickly (n=13/50), and felt that the risk of infection was low (n=10/50). Patients (47%) would decline IR donor kidneys for fear of infection transmission (n=34/76), perceived poor-quality kidneys (n=32/76), and their health was good enough to wait for an average-risk kidney (n=23/76). Undecided patients (22%) needed information about the donation situation. Patients desired information about IR donors, their kidneys, and their impact on patients' health. CONCLUSIONS:Patients confuse risk posed by OPTN-defined IR donors and other non-standard risk donors. Greater efforts are needed to educate kidney transplant candidates about IR donor kidneys and refine terminology used to describe risks to patients.
Authors: Megan L Salter; Natasha Gupta; Elizabeth King; Karen Bandeen-Roche; Andrew H Law; Mara A McAdams-DeMarco; Lucy A Meoni; Bernard G Jaar; Stephen M Sozio; Wen Hong Linda Kao; Rulan S Parekh; Dorry L Segev Journal: Clin J Am Soc Nephrol Date: 2014-09-11 Impact factor: 8.237
Authors: D Neofytos; K Kobayashi; C D Alonso; J Cady-Reh; D Lepley; M Harris; N Desai; E Kraus; A Subramanian; S Treadway; D Ostrander; C Thompson; K Marr Journal: Transpl Infect Dis Date: 2012-11-23 Impact factor: 2.228
Authors: Shanti M Seaman; Sarah E Van Pilsum Rasmussen; Anh Q Nguyen; Samantha E Halpern; Susan You; Madeleine M Waldram; Saad K Anjum; Mary Grace Bowring; Abimereki D Muzaale; Darin B Ostrander; Diane Brown; Allan B Massie; Aaron A R Tobian; Macey L Henderson; Faith E Fletcher; Burke Smith; Ada Chao; Nishita Gorupati; Katya Prakash; Saima Aslam; Dong H Lee; Varvara Kirchner; Timothy L Pruett; Ghady Haidar; Kailey Hughes; Maricar Malinis; Sonya Trinh; Dorry L Segev; Jeremy Sugarman; Christine M Durand Journal: J Acquir Immune Defic Syndr Date: 2020-09-01 Impact factor: 3.771
Authors: Teri Browne; Ahinee Amamoo; Rachel E Patzer; Jenna Krisher; Henry Well; Jennifer Gander; Stephen O Pastan Journal: BMC Nephrol Date: 2016-07-30 Impact factor: 2.388
Authors: Alessandra Agnese Grossi; Federico Nicoli; Tullia Maria De Feo; Massimo Cardillo; Gabriella Biffa; Renzo Pegoraro; Carlo Petrini; Rosanna Torelli; Francesca Puoti; Giuseppe Rossini; Giuseppe Piccolo; Sergio Vesconi; Enrico Minetti; Barbara Pozzo; Giuseppe Vanacore; David Paredes; Paolo Antonio Grossi; Mario Picozzi Journal: Transplant Direct Date: 2021-10-22
Authors: Yvonne M Kelly; Arya Zarinsefat; Mehdi Tavakol; Amy M Shui; Chiung-Yu Huang; John P Roberts Journal: BMC Med Ethics Date: 2022-03-05 Impact factor: 2.652